HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,513-1,524 of 1,979
Drug study icon
CompletedEUCTR 2016-000756-98

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Cariprazine in Patients with Bipo...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
Bipolarity, DepressionHistorical research record
Countries
Bulgaria, Croatia, Slovakia
Sponsor
Forest Laboratories LLC, an Allergan Affiliate
Drug study icon
CompletedEUCTR 2015-003331-36

A Phase IV, Open-label, Non-randomized, Clinical Trial to Evaluate the Safety of self-administered ADASUVE(R) (Staccato loxapine for inhalation) in Agitated Patients outside the hospital setting

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
Schizophrenia, BipolarityHistorical research record
Countries
Austria, Norway
Sponsor
FERRER INTERNACIONAL SA
Drug study icon
Active Not RecruitingEUCTR 2021-003676-13

Comparing esketamine plus propofol with methohexital anaesthesia during ECT for severe depression

About this title

A prospective randomized, single blind, controlled, safety and non-inferiority study of esketamine plus propofol compared to methohexital anesthesia for electroconvulsive therapy

Read the official source — 2024-512210-18-00
Official study title

A prospective randomized, double blind, controlled, safety and non-inferiority study of esketamine plus propofol compared to methohexital anesthesia for electroconvulsive therapy

Original registry wording; source language not specified.

This study is no longer accepting new participants.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

In Vienna
Bipolarity, DepressionHistorical research record
Countries
Austria
Sponsor
Medical University of Vienna
Drug study icon
CompletedEUCTR 2006-000846-38

A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Extended-Release Paliperidone as Maintenance Treatment After an ...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
BipolarityHistorical research record
Countries
Germany
Sponsor
Janssen-Cilag International N.V.
Drug study icon
CompletedEUCTR 2005-005812-25

A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone Compared with Flexi...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Greece
BipolarityHistorical research record
Countries
Greece, Lithuania
Sponsor
Janssen-Cilag International N.V.
Drug study icon
CompletedEUCTR 2006-001490-15

A randomized, double-blind, placebo- and active-controlled, parallel-group study to evaluate the efficacy and safety of risperidone long-acting injectable for the prevention of mood episodes in the...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
BipolarityHistorical research record
Countries
Germany, Greece
Sponsor
Janssen-Cilag International N.V
Drug study icon
CompletedEUCTR 2005-005345-19

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone as Adjunctive Therapy to Mood S...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
BipolarityHistorical research record
Countries
Belgium, Estonia
Sponsor
Janssen-Cilag International N.V.
Drug study icon
CompletedEUCTR 2007-007555-14

An 8-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/day) as Adjunctive Therapy in Adults With Major ...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
Bipolarity, DepressionHistorical research record
Countries
Bulgaria, Hungary
Sponsor
Cephalon, Inc.
Drug study icon
CompletedEUCTR 2004-004909-16

An International, Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase III study of the Efficacy and Safety of Quetiapine Fumarate (Seroquel™, single oral 300 mg or 600...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In United Kingdom
Depression, BipolarityHistorical research record
Countries
United Kingdom
Sponsor
AstraZeneca AB

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.